BE PHARMS FDA Approval ANDA 214804

ANDA 214804

BE PHARMS

FDA Drug Application

Application #214804

Application Sponsors

ANDA 214804BE PHARMS

Marketing Status

Prescription001

Application Products

001INJECTABLE;INJECTION1,000 UNITS/ML0HEPARIN SODIUMHEPARIN SODIUM

FDA Submissions

UNKNOWN; ORIG1AP2020-12-29STANDARD

Submissions Property Types

ORIG1Null15

TE Codes

001PrescriptionAP

CDER Filings

BE PHARMS
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 214804
            [companyName] => BE PHARMS
            [docInserts] => ["",""]
            [products] => [{"drugName":"HEPARIN SODIUM","activeIngredients":"HEPARIN SODIUM","strength":"1,000 UNITS\/ML","dosageForm":"INJECTABLE;INJECTION","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"12\/29\/2020","submission":"ORIG-1","actionType":"Approval","submissionClassification":"","reviewPriority":"STANDARD","inserts":"[]","notes":"> Label is not available on this site."}]
            [supplements] => 
            [actionDate] => 2020-12-29
        )

)

© 2021 FDA.report
This site is not affiliated with or endorsed by the FDA.